Sign in
4

Changes in Ownership

NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001709738-23-000016

Business Development Director sold 38,293 shares at an average $1.44 ($55,129)

From the SEC's structured data for this filing

Trades in this filing

Christianson Mark · Business Development Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-26 Sale : show line 1 in the form −6,848 $1.35 $9,269 332,039 D
2023-12-27 Sale : show line 2 in the form −31,445 $1.46 $45,859 300,594 D
Open-market sales · 38,293 sh · avg $1.44 · $55,129
Loading xslF345X05/primary_doc.xml…